<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Pipeline Tracker | Statmint</title>
  <meta name="description" content="Real biotech pipeline tracker with full-width professional layout and verified company data.">
  <link rel="icon" href="statmint_logo.jpeg" type="image/jpeg" />
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css" rel="stylesheet"/>
  <link href="https://unpkg.com/aos@2.3.4/dist/aos.css" rel="stylesheet"/>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600&family=Merriweather:wght@700&display=swap" rel="stylesheet"/>
  <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
  <style>
    body {
      font-family: 'Inter', sans-serif;
      background: #f9fafb;
      color: #212529;
    }

    header {
      background: #0a0a0a;
      padding: 1rem 2rem;
      display: flex;
      justify-content: space-between;
      align-items: center;
      position: sticky;
      top: 0;
    }

    header img { height: 44px; }
    nav a {
      margin-left: 1.5rem;
      color: #fff;
      text-decoration: none;
      font-weight: 500;
    }
    nav a:hover { color: #0d6efd; }

    .hero {
      background: #0a0a0a;
      color: #fff;
      text-align: center;
      padding: 4rem 1rem;
    }

    .hero h1 {
      font-family: 'Merriweather', serif;
      font-size: 2.5rem;
    }

    .hero p {
      max-width: 1000px;
      margin: 1rem auto 0;
      color: #adb5bd;
    }

    .full-width-table {
      width: 100%;
      border-collapse: collapse;
      margin-top: 2rem;
      table-layout: fixed;
    }

    th, td {
      padding: 0.75rem 1rem;
      border: 1px solid #dee2e6;
      text-align: left;
      vertical-align: top;
      word-wrap: break-word;
    }

    th {
      background: #f8f9fa;
      font-weight: 600;
    }

    tbody tr:nth-child(even) {
      background: #fdfdfe;
    }

    tbody tr:hover {
      background: #e9ecef;
    }

    .sparkline {
      height: 40px;
      width: 100px;
    }

    footer {
      background: #0a0a0a;
      color: #adb5bd;
      text-align: center;
      padding: 2rem 1rem;
    }

    footer a {
      color: #0d6efd;
    }

    /* Make sure table container is truly fluid */
    .table-container {
      width: 100%;
      overflow-x: auto;
    }
  </style>
</head>

<body>

<header>
  <a href="index.html"><img src="statmint_logo.jpeg" alt="Statmint Logo"></a>
  <nav>
    <a href="index.html">Home</a>
    <a href="stocks.html">Pipeline Tracker</a>
    <a href="fda.html">FDA Pipeline</a>
    <a href="ipos.html">Biotech IPOs</a>
  </nav>
</header>

<section class="hero">
  <h1>Emerging Biotech Pipeline Tracker</h1>
  <p>Statmint provides factual summaries and trial data for real biotech companies — full-width view for clarity and easy comparison.</p>
</section>

<section class="table-container px-3 py-5">
  <table class="full-width-table">
    <thead>
      <tr>
        <th>Company</th>
        <th>Summary</th>
        <th>Ticker</th>
        <th>Candidate</th>
        <th>Indication</th>
        <th>Phase</th>
        <th>Trial Status</th>
        <th>Competitors</th>
        <th>IPO Date</th>
        <th>Price Trend</th>
        <th>Links</th>
      </tr>
    </thead>
    <tbody id="pipeline-table-body"></tbody>
  </table>
</section>

<footer>
  <div class="container">
    <p>© 2025 Statmint. For research use only. <a href="#">Privacy Policy</a>.</p>
  </div>
</footer>

<script src="https://unpkg.com/aos@2.3.4/dist/aos.js"></script>
<script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
<script>
  AOS.init({ duration: 800, once: true, easing: 'ease-in-out' });

  const pipeline = [
    {
      name: "Moderna",
      summary: "Moderna is a pioneer in mRNA therapeutics, developing vaccines and treatments across infectious diseases, oncology, and rare diseases.",
      ticker: "MRNA",
      candidate: "mRNA-1345",
      indication: "RSV Vaccine (Older Adults)",
      phase: "Phase III",
      trialStatus: "Primary endpoint met; BLA filing expected late 2024.",
      competitors: ["Pfizer", "GSK"],
      ipoDate: "Dec 2018",
      prices: [140, 145, 142, 148, 150, 153, 155, 160, 162, 158, 155, 150],
      website: "https://www.modernatx.com"
    },
    {
      name: "BioNTech",
      summary: "BioNTech develops mRNA-based immunotherapies for cancer and infectious diseases; co-developed the first mRNA COVID-19 vaccine with Pfizer.",
      ticker: "BNTX",
      candidate: "BNT162b2 Combo",
      indication: "COVID-19 + Influenza Combo Vaccine",
      phase: "Phase II/III",
      trialStatus: "Enrolling; interim data mid-2024.",
      competitors: ["Moderna", "CureVac"],
      ipoDate: "Oct 2019",
      prices: [100, 98, 95, 97, 99, 102, 105, 104, 107, 110, 108, 105],
      website: "https://biontech.com"
    },
    {
      name: "Vertex Pharmaceuticals",
      summary: "Vertex is a biotech leader in cystic fibrosis treatment and now expanding into non-opioid pain and gene editing therapies.",
      ticker: "VRTX",
      candidate: "VX-548",
      indication: "Non-opioid Pain Treatment",
      phase: "Phase III",
      trialStatus: "Pivotal trials enrolling; NDA filing planned for 2025.",
      competitors: ["Pfizer", "Eli Lilly"],
      ipoDate: "July 1991",
      prices: [300, 310, 320, 315, 318, 325, 330, 340, 335, 345, 340, 335],
      website: "https://www.vrtx.com"
    },
    {
      name: "Alnylam Pharmaceuticals",
      summary: "Alnylam focuses on RNAi therapeutics to silence disease-causing genes, with approved products and new late-stage candidates.",
      ticker: "ALNY",
      candidate: "Vutrisiran",
      indication: "ATTR Amyloidosis",
      phase: "Phase III",
      trialStatus: "On track for Phase III readout Q3 2024.",
      competitors: ["Ionis Pharmaceuticals"],
      ipoDate: "Jun 2004",
      prices: [190, 195, 192, 198, 200, 205, 202, 207, 210, 208, 205, 200],
      website: "https://www.alnylam.com"
    },
    {
      name: "CRISPR Therapeutics",
      summary: "CRISPR Therapeutics develops gene-editing therapies using CRISPR/Cas9 tech, with lead programs in blood disorders.",
      ticker: "CRSP",
      candidate: "CTX001",
      indication: "Beta Thalassemia & Sickle Cell",
      phase: "Regulatory Review",
      trialStatus: "BLA submitted; under FDA review 2024.",
      competitors: ["Bluebird Bio"],
      ipoDate: "Oct 2016",
      prices: [50, 52, 55, 57, 59, 60, 63, 65, 62, 60, 58, 57],
      website: "https://www.crisprtx.com"
    }
  ];

  const labels = ["Jul 2023","Aug","Sep","Oct","Nov","Dec","Jan","Feb","Mar","Apr","May","Jun"];
  const tbody = document.getElementById('pipeline-table-body');

  pipeline.forEach((entry, idx) => {
    const row = document.createElement('tr');
    row.innerHTML = `
      <td>${entry.name}</td>
      <td>${entry.summary}</td>
      <td>${entry.ticker}</td>
      <td>${entry.candidate}</td>
      <td>${entry.indication}</td>
      <td>${entry.phase}</td>
      <td>${entry.trialStatus}</td>
      <td>${entry.competitors.join(', ')}</td>
      <td>${entry.ipoDate}</td>
      <td><canvas id="spark-${idx}" class="sparkline"></canvas></td>
      <td>
        <a href="${entry.website}" target="_blank">IR Page</a> |
        <a href="https://finance.yahoo.com/quote/${entry.ticker}" target="_blank">Yahoo Finance</a>
      </td>
    `;
    tbody.appendChild(row);

    const ctx = document.getElementById(`spark-${idx}`).getContext('2d');
    new Chart(ctx, {
      type: 'line',
      data: {
        labels: labels,
        datasets: [{
          data: entry.prices,
          borderColor: '#0d6efd',
          backgroundColor: 'transparent',
          tension: 0.3
        }]
      },
      options: {
        plugins: { legend: { display: false } },
        scales: {
          x: { display: false },
          y: { display: false }
        },
        elements: {
          point: { radius: 0 }
        }
      }
    });
  });
</script>

</body>
</html>
